{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:39:40Z","timestamp":1777088380561,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RO1AG054671"],"award-info":[{"award-number":["RO1AG054671"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["DP5OD019833"],"award-info":[{"award-number":["DP5OD019833"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Massachusetts General Hospital Executive Committee on Research"},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["2019A005859"],"award-info":[{"award-number":["2019A005859"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To determine whether performance on the Latin American Spanish version of the Face-Name Associative Memory Exam (LAS-FNAME) can differentiate between cognitively intact carriers of an autosomal dominant Alzheimer\u2019s disease mutation (E280A) in Presenilin-1, who are genetically determined to develop early-onset dementia, from matched non-carriers. We also sought to examine whether LAS-FNAME performance is associated with amyloid-\u03b2 and regional tau burden in mutation carriers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 35 cognitively intact mutation carriers (age range 26\u201341), 19 symptomatic carriers, and 48 matched non-carriers (age range 27\u201344) completed a neuropsychological assessment including the LAS-FNAME. A subset of participants (31 carriers [12 symptomatic] and 35 non-carriers) traveled from Colombia to Boston to undergo positron emission tomography (PET) using Pittsburgh compound B to measure mean cortical amyloid-\u03b2 and flortaucipir for regional tau. ANOVA analyses and Spearman correlations were used to examine group differences and relationships among LAS-FNAME performance and amyloid-\u03b2 and tau accumulation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to non-carriers, cognitively intact mutation carriers had lower scores on the LAS-FNAME Total Scores (<jats:italic>p<\/jats:italic>\u2009=\u2009.040). Across all carriers (including symptomatic carriers), higher levels of amyloid-\u03b2 (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u2009.436, <jats:italic>p<\/jats:italic>\u2009=\u2009.018) and regional tau in the entorhinal (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u2009.394, <jats:italic>p<\/jats:italic>\u2009=\u2009.031) and inferior temporal cortex (<jats:italic>r<\/jats:italic>\u2009=\u2009\u2212\u2009.563, <jats:italic>p<\/jats:italic>\u2009=\u2009.001) were associated with lower LAS-FNAME Total Scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Performance on the LAS-FNAME differentiated between cognitively intact mutation carriers from non-carriers and was associated with greater amyloid and tau burden when examining all carriers. Findings suggest that the LAS-FNAME is sensitive to early clinical and pathological changes and can potentially help track disease progression in Spanish-speaking individuals.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-020-00671-w","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T12:03:37Z","timestamp":1599739417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"12","author":[{"given":"Clara","family":"Vila-Castelar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn V.","family":"Papp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca E.","family":"Amariglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Baena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmarie","family":"Guzm\u00e1n-V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamile","family":"Bocanegra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin S.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M.","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reisa A.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Lopera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorene M.","family":"Rentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yakeel T.","family":"Quiroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"671_CR1","doi-asserted-by":"crossref","unstructured":"Alzheimer's Association. 2019 Alzheimer's disease facts and figures. Alzheimers Dement. 2019;15(3):321\u201387.","DOI":"10.1016\/j.jalz.2019.01.010"},{"issue":"3","key":"671_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jalz.2015.12.007","volume":"12","author":"ER Mayeda","year":"2016","unstructured":"Mayeda ER, Glymour MM, Quesenberry CP, Whitmer RA. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimers Dement. 2016;12(3):216\u201324.","journal-title":"Alzheimers Dement"},{"key":"671_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fnagi.2017.00221","volume":"9","author":"N Custodio","year":"2017","unstructured":"Custodio N, Wheelock A, Thumala D, Slachevsky A. Dementia in Latin America: epidemiological evidence and implications for public policy. Front Aging Neurosci. 2017;9:221.","journal-title":"Front Aging Neurosci"},{"issue":"]","key":"671_CR4","doi-asserted-by":"publisher","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","volume":"6","author":"R Sperling","year":"2014","unstructured":"Sperling R, Rentz DM, Johnson KA, Karlawish J, Donohue M, Salmon DP, et al. The A4 study: stopping AD before symptoms begin? Sci Transl Med. 2014;6(]):228fs13.","journal-title":"Sci Transl Med"},{"key":"671_CR5","doi-asserted-by":"publisher","unstructured":"Vila-Castelar C, Papp KV, Amariglio RE, Torres VL, Baena A, Gomez D, et al. Validation of the Latin American Spanish version of the face-name associative memory exam in a Colombian Sample. Clin Neuropsychol. 2019:1\u201312. https:\/\/doi.org\/10.1080\/13854046.2019.1690050.","DOI":"10.1080\/13854046.2019.1690050"},{"issue":"5","key":"671_CR6","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/13854046.2014.911351","volume":"28","author":"KV Papp","year":"2014","unstructured":"Papp KV, Amariglio RE, Dekhtyar M, Roy K, Wigman S, Bamfo R, et al. Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectory. Clin Neuropsychol. 2014;28(5):771\u201385.","journal-title":"Clin Neuropsychol"},{"issue":"9","key":"671_CR7","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1016\/j.neuropsychologia.2011.06.006","volume":"49","author":"DM Rentz","year":"2011","unstructured":"Rentz DM, Amariglio RE, Becker JA, Frey M, Olson LE, Frishe K, et al. Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia. 2011;49(9):2776\u201383.","journal-title":"Neuropsychologia."},{"issue":"12","key":"671_CR8","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1016\/j.neuropsychologia.2012.08.011","volume":"50","author":"RE Amariglio","year":"2012","unstructured":"Amariglio RE, Becker JA, Carmasin J, Wadsworth LP, Lorius N, Sullivan C, et al. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia. 2012;50(12):2880\u20136.","journal-title":"Neuropsychologia."},{"issue":"2","key":"671_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2009.07.003","volume":"63","author":"R Sperling","year":"2009","unstructured":"Sperling R, Laviolette PS, O'Keefe K, O'Brien J, Rentz DM, Pihlajamaki M, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron. 2009;63(2):178\u201388.","journal-title":"Neuron."},{"issue":"1","key":"671_CR10","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1038\/s41598-018-21644-y","volume":"8","author":"A Sanabria","year":"2018","unstructured":"Sanabria A, Alegret M, Rodriguez-Gomez O, Valero S, Sotolongo-Grau O, Monte-Rubio G, et al. The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline. Sci Rep. 2018;8(1):3828.","journal-title":"Sci Rep"},{"issue":"1","key":"671_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00594-6","volume":"12","author":"M Alegret","year":"2020","unstructured":"Alegret M, Mu\u00f1oz N, Roberto N, Rentz DM, Valero S, Gil S, et al. A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory\u00ae) for the early detection of Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12(1):1\u201311.","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"671_CR12","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/S1053-8119(03)00391-4","volume":"20","author":"R Sperling","year":"2003","unstructured":"Sperling R, Chua E, Cocchiarella A, Rand-Giovannetti E, Poldrack R, Schacter DL, et al. Putting names to faces:: Successful encoding of associative memories activates the anterior hippocampal formation. Neuroimage. 2003;20(2):1400\u201310.","journal-title":"Neuroimage."},{"issue":"3","key":"671_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","volume":"7","author":"CR Jack Jr","year":"2011","unstructured":"Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):257\u201362.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"671_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1474-4422(10)70323-9","volume":"10","author":"N Acosta-Baena","year":"2011","unstructured":"Acosta-Baena N, Sepulveda-Falla D, Lopera-G\u00f3mez CM, Jaramillo-Elorza MC, Moreno S, Aguirre-Acevedo DC, et al. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer\u2019s disease: a retrospective cohort study. Lancet Neurol. 2011;10(3):213\u201320.","journal-title":"Lancet Neurol"},{"issue":"3","key":"671_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"671_CR16","first-page":"653","volume":"24","author":"B Reisberg","year":"1988","unstructured":"Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull. 1988;24(4):653\u20139.","journal-title":"Psychopharmacol Bull"},{"issue":"1","key":"671_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","volume":"17","author":"JA Yesavage","year":"1982","unstructured":"Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37\u201349.","journal-title":"J Psychiatr Res"},{"issue":"5","key":"671_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamaneurol.2017.4907","volume":"75","author":"YT Quiroz","year":"2018","unstructured":"Quiroz YT, Sperling RA, Norton DJ, Baena A, Arboleda-Velasquez JF, Cosio D, et al. Association between amyloid and tau accumulation in young adults with autosomal dominant Alzheimer disease. JAMA Neurol. 2018;75(5):548\u201356.","journal-title":"JAMA Neurol"},{"issue":"5","key":"671_CR19","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","volume":"10","author":"J Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10(5):740\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"671_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1212\/WNL.0000000000001712","volume":"85","author":"RE Amariglio","year":"2015","unstructured":"Amariglio RE, Mormino EC, Pietras AC, Marshall GA, Vannini P, Johnson KA, et al. Subjective cognitive concerns, amyloid-beta, and neurodegeneration in clinically normal elderly. Neurology. 2015;85(1):56\u201362.","journal-title":"Neurology."},{"issue":"1","key":"671_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016;79(1):110\u20139.","journal-title":"Ann Neurol"},{"issue":"5","key":"671_CR22","first-page":"904","volume":"39","author":"OG Rousset","year":"1998","unstructured":"Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 1998;39(5):904\u201311.","journal-title":"J Nucl Med"},{"issue":"1","key":"671_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/JAD-130098","volume":"38","author":"DT Chien","year":"2014","unstructured":"Chien DT, Szardenings AK, Bahri S, Walsh JC, Mu F, Xia C, et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808. J Alzheimers Dis. 2014;38(1):171\u201384.","journal-title":"J Alzheimers Dis"},{"key":"671_CR24","unstructured":"IBM SPSS Statistics for Windows. 25 ed. Armonk: IBM Corp; 2017."},{"issue":"16","key":"671_CR25","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1523\/JNEUROSCI.5053-03.2004","volume":"24","author":"C Ranganath","year":"2004","unstructured":"Ranganath C, Cohen MX, Dam C, D'Esposito M. Inferior temporal, prefrontal, and hippocampal contributions to visual working memory maintenance and associative memory retrieval. J Neurosci. 2004;24(16):3917\u201325.","journal-title":"J Neurosci"},{"issue":"45","key":"671_CR26","doi-asserted-by":"publisher","first-page":"12075","DOI":"10.1073\/pnas.1713308114","volume":"114","author":"VA Carr","year":"2017","unstructured":"Carr VA, Bernstein JD, Favila SE, Rutt BK, Kerchner GA, Wagner AD. Individual differences in associative memory among older adults explained by hippocampal subfield structure and function. Proc Natl Acad Sci U S A. 2017;114(45):12075\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"671_CR27","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1523\/JNEUROSCI.3769-16.2017","volume":"37","author":"SM Marks","year":"2017","unstructured":"Marks SM, Lockhart SN, Baker SL, Jagust WJ. Tau and beta-amyloid are associated with medial temporal lobe structure, function, and memory encoding in Normal aging. J Neurosci. 2017;37(12):3192\u2013201.","journal-title":"J Neurosci"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00671-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-020-00671-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00671-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T23:39:12Z","timestamp":1631230752000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00671-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["671"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00671-w","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,10]]},"assertion":[{"value":"11 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for this study was obtained from the University of Antioquia (Colombia) Ethics Committee and the Partners Human Research Institutional Review Board. Participants provided written informed consent before enrollment into the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}